Blood–Brain Barrier Pathology in Alzheimer's and Parkinson's Disease: Implications for Drug Therapy

Alzheimer’s disease

Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

J. Submicrosc. Cytol. Pathol.

Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800 · see citing works

Stages in the development of Parkinson’s disease-related pathology

Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · see citing works

Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M. F., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3473 · Cited by 2,366 · see citing works

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

Schinkel, A. H., Smit, J., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., Riele, H. T., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,284 · see citing works

Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice

Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917 · see citing works

Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · see citing works

Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier

Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413 · see citing works

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · see citing works

Astrocyte-endothelial Interactions and Blood-Brain Barrier Permeability*

Abbott, N. J. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00064.x · Cited by 1,168 · see citing works

Cerebral microvascular pathology in aging and Alzheimer's disease

Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · see citing works

Microglia and neuroinflammation: a pathological perspective

Streit (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-14 · Cited by 1,039 · see citing works

THE CELL BIOLOGY OF THE BLOOD-BRAIN BARRIER

Rubin, L. L., & Staddon, J. M. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.11 · Cited by 1,005 · see citing works

Complement activation by beta-amyloid in Alzheimer disease.

Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817 · see citing works

The large apparent work capability of the blood‐brain barrier: A study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat

Oldendorf, W. H., Cornford, M. E., & Brown, W. J. (1977) · Annals of Neurology · doi:10.1002/ana.410010502 · Cited by 651 · see citing works

Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology

Deli, M. A., Ábrahám, C. S., Kataoka, Y., & Niwa, M. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1377-8 · Cited by 643 · see citing works

TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice

Wyss-Coray, T., Lin, C., Yan, F., Yu, G.-Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001) · Nature Medicine · doi:10.1038/87945 · Cited by 587 · see citing works

Blood-brain barrier transport of cytokines: a mechanism for neuropathology

Banks, W. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381684 · Cited by 534 · see citing works

Tight Junctions of the Blood–Brain Barrier

Kniesel, U., & Wolburg, H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006995910836 · Cited by 525 · see citing works

Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme

Liebner, S., Fischmann, A., Rascher, G., Duffner, F., Grote, E.-H., Kalbacher, H., & Wolburg, H. (2000) · Acta Neuropathologica · doi:10.1007/s004010000180 · Cited by 490 · see citing works

Immune System Response in Alzheimer's Disease

McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 460 · see citing works

Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease

Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., & Mucke, L. (1997) · Nature · doi:10.1038/39321 · Cited by 417 · see citing works

Neuroinflammatory processes in Parkinson's disease

Hunot, S., & Hirsch, É. C. (2003) · Annals of Neurology · doi:10.1002/ana.10481 · Cited by 399 · see citing works

Microglia and inflammatory mechanisms in the clearance of amyloid β peptide

Rogers, J., Strohmeyer, R., Kovelowski, C. J., & Li, R. (2002) · Glia · doi:10.1002/glia.10153 · Cited by 381 · see citing works

The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse

Kurkowska‐Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6993 · Cited by 379 · see citing works

Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood–brain barrier breakdown in vivo

Bolton, S. J., Anthony, D. C., & Perry, V. H. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00058-x · Cited by 370 · see citing works

Cellular pathology of Parkinson?s disease: astrocytes, microglia and inflammation

Teismann, P., & Schulz, J. B. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0944-0 · Cited by 363 · see citing works

Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia

Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., & Kumar, P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00285-8 · Cited by 360 · see citing works

Brain pericytes contribute to the induction and up-regulation of blood–brain barrier functions through transforming growth factor-β production

Dohgu, S., Takata, F., Yamauchi, A., Nakagawa, S., Egawa, T., Naito, M., Tsuruo, T., Sawada, Y., Niwa, M., & Kataoka, Y. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.027 · Cited by 350 · see citing works

Cell therapy in Parkinson’s disease

Lindvall, O., & Björklund, A. (2004) · NeuroRx · doi:10.1602/neurorx.1.4.382 · Cited by 348 · see citing works

Deposition of Alzheimer's ??-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans

Vogelgesang, S., Cascorbi, I., Schroeder, E., Pahnke, J., Kroemer, H. K., Siegmund, W., Kunert‐Keil, C., Walker, L. C., & Warzok, R. (2002) · Pharmacogenetics · doi:10.1097/00008571-200210000-00005 · Cited by 344 · see citing works

Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease

Kalaria, R. N., & Harik, S. I. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07399.x · Cited by 338 · see citing works

Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia

Nakayama, M., Uchimura, K., Zhu, R. L., Nagayama, T., Rose, M. E., Stetler, R. A., Isakson, P. C., Chen, J., & Graham, S. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10954 · Cited by 337 · see citing works

Alterations of T-lymphocyte populations in Parkinson disease

Baba, Y., Kuroiwa, A., Uitti, R. J., Wszolek, Z. K., & Yamada, T. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.07.005 · Cited by 336 · see citing works

Microglia and Alzheimer's disease pathogenesis

Streit, W. J. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20093 · Cited by 335 · see citing works

In Search of the Astrocytic Factor(s) Modulating Blood–Brain Barrier Functions in Brain Capillary Endothelial Cells In Vitro

Haseloff, R. F., Blasig, I. E., Bauer, H., & Bauer, H. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1375-x · Cited by 301 · see citing works

Glial cell influence on the human blood‐brain barrier

Prat, A., Biernacki, K., Wosik, K., & Antel, J. P. (2001) · Glia · doi:10.1002/glia.1104 · Cited by 269 · see citing works

Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood–brain barrier

Wong, D. K., Dorovini‐Zis, K., & Vincent, S. R. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.008 · Cited by 264 · see citing works

Molecular and Cellular Characterization of the Membrane Attack Complex, C5b-9, in Alzheimer’s Disease

Webster, S. D., Lue, L., Brachova, L., Tenner, A. J., McGeer, P. L., Terai, K., Walker, D. G., Bradt, B. M., Cooper, N. R., & Rogers, J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00042-0 · Cited by 258 · see citing works

THE TIGHT JUNCTION: Morphology to Molecules

Stevenson, B. R., & Keon, B. H. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.89 · Cited by 256 · see citing works

Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys

Judith Miklossy, A., Doudet, D., Schwab, C., Yu, S. Y., McGeer, E. G., & McGeer, P. L. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.034 · Cited by 255 · see citing works

A population study on blood-brain barrier function in 85-year-olds

Skoog, I. G., Wallin, A., Fredman, P., Hesse, C., Aevarsson, Ó., Karlsson, I., Gottfries, C. G., & Blennow, K. (1998) · Neurology · doi:10.1212/wnl.50.4.966 · Cited by 238 · see citing works

Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies

van der Wal, E. A., Gómez‐Pinilla, F., & Cotman, C. W. (1993) · Neuroreport · doi:10.1097/00001756-199301000-00018 · Cited by 230 · see citing works

Mechanisms of the Blood–Brain Barrier Disruption in HIV-1 Infection

Toborek, M. J., Lee, Y. W., Flora, G., Pu, H., Andras, I. E., Wylęgała, E., Hennig, B., & Nath, A. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1383-x · Cited by 228 · see citing works

Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons

McGuire, S. O., Ling, Z. D., Lipton, J. W., Sortwell, C. E., Collier, T. J., & Carvey, P. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7688 · Cited by 222 · see citing works

Blood vessels change in the mesencephalon of patients with Parkinson's disease

Faucheux, B. A., Agid, Y., Hirsch, É. C., & Bonnet, A.-M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00641-8 · Cited by 218 · see citing works

6-Hydroxydopamine-induced alterations in blood-brain barrier permeability

Carvey, P. M., Zhao, C. H., Hendey, B., Lum, H., Trachtenberg, J., Desai, B. S., Snyder, J., Zhu, Y. G., & Ling, Z. D. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04281.x · Cited by 218 · see citing works

Occludin as direct target for glucocorticoid‐induced improvement of blood–brain barrier properties in a murinein vitrosystem

Förster, C. Y., Silwedel, C., Golenhofen, N., Burek, M., Kietz, S., Mankertz, J., & Drenckhahn, D. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.084038 · Cited by 212 · see citing works

Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients

Cláudio, L. (1995) · Acta Neuropathologica · doi:10.1007/s004010050386 · Cited by 210 · see citing works

Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats

Huber, J. D., VanGilder, R. L., & Houser, K. A. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00489.2006 · Cited by 206 · see citing works

Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure

Barcia, C., Sánchez-Bahíllo, A., Fernández‐Villalba, E., Bautista‐Hernández, V., Poza, M., Fernández-Barreiro, A., Hirsch, É. C., & Herrero, M. T. (2004) · Glia · doi:10.1002/glia.20015 · Cited by 206 · see citing works

Rapid Modulation of P-Glycoprotein-Mediated Transport at the Blood-Brain Barrier by Tumor Necrosis Factor-α and Lipopolysaccharide

Hartz, A. M. S., Bauer, B., Fricker, G., & Miller, D. S. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017954 · Cited by 203 · see citing works

Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus

Baik, E. J., Kim, E. J., Lee, S., & Moon, C. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01797-7 · Cited by 200 · see citing works

GLUT-1 Expression in the Cerebra of Patients with Alzheimer’s Disease

Mooradian, A. D., Chung, H. C., & Shah, G. N. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00111-5 · Cited by 199 · see citing works

Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia

Kalaria, R. N., Cohen, D., Premkumar, D. R., Nag, S., LaManna, J. C., & Lust, W. D. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00190-9 · Cited by 190 · see citing works

T-Cells in Alzheimer's Disease

Town, T., Tan, J., Flavell, R. A., & Mullan, M. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:3:255 · Cited by 183 · see citing works

TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice

Zhao, C., Ling, Z., Newman, M. B., Bhatia, A., & Carvey, P. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.012 · Cited by 183 · see citing works

The etiology of Parkinson's disease with emphasis on the MPTP story

Langston, J. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.153s · Cited by 180 · see citing works

Expression polymorphism of the blood???brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease

Furuno, T., Landi, M.-T., Ceroni, M., Caporaso, N., Bernucci, I., Nappi, G., Martignoni, E., Schaeffeler, E., Eichelbaum, M., Schwab, M., et al. (2002) · Pharmacogenetics · doi:10.1097/00008571-200210000-00004 · Cited by 178 · see citing works

Amyloid β-peptide1–42 alters tight junction protein distribution and expression in brain microvessel endothelial cells

Marco, S., & Skaper, S. D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.047 · Cited by 172 · see citing works

Co-accumulation of vascular endothelial growth factor with β-amyloid in the brain of patients with Alzheimer’s disease

Yang, S., Bae, D., Kang, H. J., Gwag, B. J., Gho, Y. S., & Chae, C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00111-8 · Cited by 170 · see citing works

Microvascular Dysfunction in Sepsis

Lush, C. W., & Kvietys, P. R. (2000) · Microcirculation · doi:10.1038/sj.mn.7300096 · Cited by 166 · see citing works

Progressive Dopamine Neuron Loss in Parkinson's Disease: The Multiple Hit Hypothesis

Carvey, P. M., Punati, A., & Newman, M. B. (2006) · Cell Transplantation · doi:10.3727/000000006783981990 · Cited by 164 · see citing works

Structural and Functional Variations in Capillary Systems within the Braina

Fenstermacher, J. D., Gross, P. M., Sposito, N. M., Acuff, V., Pettersen, S. E., & Gruber, K. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb51416.x · Cited by 162 · see citing works

Nanoparticle and other metal chelation therapeutics in Alzheimer disease

Liu, G., Garrett, M. R., Men, P., Zhu, X., Perry, G. L., & Smith, M. A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.06.006 · Cited by 160 · see citing works

Clinical aspects of inflammation in Alzheimer's disease

Rosenberg, P. B. (2005) · International Review of Psychiatry · doi:10.1080/02646830500382037 · Cited by 159 · see citing works

Clinical Potential of Minocycline for Neurodegenerative Disorders

BLUM, D., CHTARTO, A., TENENBAUM, L., BROTCHI, J., & LEVIVIER, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.012 · Cited by 157 · see citing works

Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55

Fábry, Z., Waldschmidt, M. M., Hendrickson, D., Keiner, J., Love-Homan, L., Takei, F., & HART, M. N. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90026-h · Cited by 155 · see citing works

Role of striatal l ‐DOPA in the production of dyskinesia in 6‐hydroxydopamine lesioned rats

Carta, M., Lindgren, H. S., Lundblad, M., Stancampiano, R., Fadda, F., & Cenci, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03696.x · Cited by 150 · see citing works

Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries

Kago, T., Takagi, N., Date, I., Takenaga, Y., Takagi, K., & Takeo, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.133 · Cited by 136 · see citing works

Astrocytes Increase the Functional Expression of P-Glycoprotein in an In Vitro Model of The Blood-Brain Barrier

Gaillard, P. J., van der Sandt, I. C. J., Voorwinden, L. H., Vu, D., Nielsen, J. L., de Boer, A. G., & Breimer, D. D. (2000) · Pharmaceutical Research · doi:10.1023/a:1026406528530 · Cited by 128 · see citing works

Increased intrathecal TGF-β1, but not IL-12, IFN-γ and IL-10 levels in Alzheimer’s disease patients

Rota, E., Bellone, G., Rocca, P., Bergamasco, B., Emanuelli, G., & Ferrero, P. (2006) · Neurological Sciences · doi:10.1007/s10072-006-0562-6 · Cited by 125 · see citing works

Neural Induction of the Blood–Brain Barrier: Still an Enigma

Bauer, H., & Bauer, H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006939825857 · Cited by 123 · see citing works

Effect of Oxidative Stress on the Junctional Proteins of Cultured Cerebral Endothelial Cells

Krizbai, I. A., Bauer, H., Bresgen, N., Eckl, P., Farkas, A. E., Szatmari, E. M., Traweger, A., Wejksza, K., & Bauer, H. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1378-7 · Cited by 123 · see citing works

Peripheral T cells overexpress MIP-1α to enhance its transendothelial migration in Alzheimer's disease

Man, S., Ma, Y., Shang, D., Zhao, W., Li, B., Guo, D., Fang, W., Zhu, L., & Chen, Y. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.013 · Cited by 122 · see citing works

Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer’s disease

Frohman, E. M., Frohman, T. C., Gupta, S., de Fougerolles, A., & van den Noort, S. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90202-i · Cited by 120 · see citing works

Aβ peptide immunization restores blood‐brain barrier integrity in Alzheimer disease

Dickstein, D. L., Biron, K. E., Ujiie, M., Pfeifer, C. G., Jeffries, A. R., & Jefferies, W. A. (2006) · The FASEB Journal · doi:10.1096/fj.05-3956com · Cited by 111 · see citing works

Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.

Poduslo, J., Curran, G., Wengenack, T. M., Malester, B., & Duff, K. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0402 · Cited by 111 · see citing works

Phagocytosis of ?/A4 amyloid fibrils of the neuritic neocortical plaques

Wisniewski, H. M., Barcikowska, M., & Kida, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00310142 · Cited by 109 · see citing works

Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease.

(1994) · PubMed Central · Cited by 105 · see citing works

Blood-brain barrier in Alzheimer dementia and in non-demented elderly

Alafuzoff, I. I., Adolfsson, R., Grundke, I., & Winblad, B. G. (1987) · Acta Neuropathologica · doi:10.1007/bf00693782 · Cited by 104 · see citing works

Neurovascular Pathways and Alzheimer Amyloid β-peptide

Zlokovic, B. V., Deane, R., Sallstrom, J., Chow, N., & Miano, J. M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00103.x · Cited by 104 · see citing works

Increased cerebrospinal fluid levels of transforming growth factor-β1 in Alzheimer’s disease

Zetterberg, H., Andreasen, N., & Blennow, K. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.001 · Cited by 101 · see citing works

Blockade of αvβ3 and αvβ5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells

Maubant, S., Saint-Dizier, D., Boutillon, M., Perron‐Sierra, F., Casara, P., Hickman, J. A., Tucker, G. C., & Obberghen‐Schilling, E. V. (2006) · Blood · doi:10.1182/blood-2006-05-023580 · Cited by 98 · see citing works

Efflux of human and mouse amyloid β proteins 1–40 and 1–42 from brain: impairment in a mouse model of alzheimer's disease

Banks, W. A., Robinson, S. M., Verma, S., & Morley, J. E. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00474-3 · Cited by 90 · see citing works

Tumor necrosis factor-α−308A/G polymorphism is associated with age at onset of Alzheimer's disease

Lio, D., Annoni, G., Licastro, F., Crivello, A., Forte, G. I., Scola, L., Colonna‐Romano, G., Candore, G., Arosio, B., Galimberti, L., et al. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.015 · Cited by 84 · see citing works

Parkinson's disease and inflammatory changes

Barcia, C., Barreiro, A. F., Poza, M., & Herrero, M. T. (2003) · Neurotoxicity Research · doi:10.1007/bf03033170 · Cited by 76 · see citing works

Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias

Mecocci, P., Parnetti, L., Reboldi, G., Santucci, C., GAITI, A., Ferri, C., Gernini, I., Romagnoli, M., Cadini, D., & Senin, U. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb04940.x · Cited by 73 · see citing works

Levodopa with benserazide or carbidopa in Parkinson disease

Rinne, U. K., & Mölsä, P. K. (1979) · Neurology · doi:10.1212/wnl.29.12.1584 · Cited by 70 · see citing works

Vascular Endothelial Growth Factor and Blood-Brain Barrier Disruption in Tuberculous Meningitis

van der Flier, M., Hoppenreijs, S., van Rensburg, A. J., Ruyken, M., Kolk, A. H. J., Springer, P. E., Hoepelman, A. I. M., Geelen, S. P. M., Kimpen, J. L. L., & Schoeman, J. F. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000131634.57368.45 · Cited by 70 · see citing works

Alzheimer's disease with and without coexisting Parkinson's disease changes

Gearing, M., Schneider, J. A., Rebeck, G. W., Hyman, B. T., & Mirra, S. S. (1995) · Neurology · doi:10.1212/wnl.45.11.1985 · Cited by 66 · see citing works

Increased plasma levels of TNF-α but not of IL1-β in MPTP-treated monkeys one year after the MPTP administration

Barcia, C., de Pablos, V., Bautista‐Hernández, V., Sánchez-Bahíllo, A., Bernal, I., Fernández‐Villalba, E., Martín, J., Bañón, R., Fernández-Barreiro, A., & Herrero, M. T. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.05.006 · Cited by 63 · see citing works

Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat

Jonkers, N., Sarre, S., Ebinger, G., & Michotte, Y. M. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170056 · Cited by 57 · see citing works

Genomewide Association, Parkinson Disease, and PARK10

Farrer, M. J., Haugarvoll, K., Ross, O. A., Stone, J. T., Milkovic, N. M., Cobb, S. A., Whittle, A. J., Lincoln, S., Hulihan, M., Heckman, M. G., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/504728 · Cited by 56 · see citing works

Alzheimer Disease and Its Management

Samanta, M. K., Wilson, B., Santhi, K., Kumar, K. P. S., & Suresh, B. (2006) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000208274.80496.f1 · Cited by 54 · see citing works

Effects of Benserazide on L-DOPA-Derived Extracellular Dopamine Levels and Aromatic L-Amino Acid Decarboxylase Activity in the Striatum of 6-Hydroxydopamine-Lesioned Rats

Shen, H., Kannari, K., Yamato, H., Arai, A., & Matsunaga, M. (2003) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.199.149 · Cited by 48 · see citing works

Increased T Cell Recruitment to the CNS after Amyloid β1–42Immunization in Alzheimer's Mice Overproducing Transforming Growth Factor-β1

Buckwalter, M. S., Coleman, B. S., Buttini, M., Barbour, R., Schenk, D., Games, D., Seubert, P. A., & Wyss‐Coray, T. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2436-06.2006 · Cited by 47 · see citing works

The potential use of a dopamine neuron antibody and a striatal‐derived neurotrophic factor as diagnostic markers in Parkinson's disease

Carvey, P. M., McRae‐Degueurce, A., Lint, T. F., Ptak, L. R., Lo, E. S., Goetz, C., & Klawans, H. L. (1991) · Neurology · doi:10.1212/wnl.41.5_suppl_2.53 · Cited by 47 · see citing works

Investigations on auto-antibodies in Alzheimer’s and Parkinson’s diseases, using defined neuronal cultures

Dahlström, A. B., Wigander, A., Lundmark, K., Gottfries, C. G., Carvey, P. M., & McRae‐Degueurce, A. (1990) · Springer eBooks · doi:10.1007/978-3-7091-9050-0_19 · Cited by 47 · see citing works

Changes in blood–brain barrier permeability following neurotoxic lesions of rat brain can be visualised with trypan blue

Reynolds, D. S., & Morton, A. J. (1998) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(97)00168-4 · Cited by 45 · see citing works

Differential deposition of amyloid β peptides in cerebral amyloid angiopathy associated with Alzheimer’s disease and vascular dementia

Haglund, M., Kalaria, R. N., Slade, J. Y., & Englund, E. M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0054-z · Cited by 45 · see citing works

Integrity of the blood–cerebrospinal fluid barrier in early Parkinson's disease

Häussermann, P., Kuhn, W., Przuntek, H., & Müller, T. H. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01574-9 · Cited by 42 · see citing works

Blood vessels and Parkinsonism

Barcia, C. (2004) · Frontiers in Bioscience · doi:10.2741/1145 · Cited by 41 · see citing works

Does Parkinson??s Disease Have an Immunological Basis?

Fiszer, U. (2001) · BioDrugs · doi:10.2165/00063030-200115060-00001 · Cited by 31 · see citing works

Amyloid β peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood–brain barrier

Poduslo, J. F., & Curran, G. L. (2001) · Neuroreport · doi:10.1097/00001756-200110290-00011 · Cited by 31 · see citing works

Alzheimer's disease and frontotemporal dementia: prospects of a tailored therapy?

Götz, J., Ittner, L. M., & Schönrock, N. (2006) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00615.x · Cited by 26 · see citing works

Neutralization of TNF by the Antibody cA2 Reveals Differential Regulation of Adhesion Molecule Expression on TNF-Activated Endothelial Cells

Nakada, M. T., Tam, S. H., Woulfe, D. S., Casper, K. A., Swerlick, R. A., & Ghrayeb, J. (1998) · Cell Communication & Adhesion · doi:10.3109/15419069809005606 · Cited by 24 · see citing works

In vivo Binding Behavior of Dopamine Receptor Agonist (+)−PD 128907 and Implications for the “Ceiling Effect” in Endogenous Competition Studies with [ 11 C]Raclopride—a Positron Emission Tomography Study in Macaca mulatta

Kortekaas, R., Maguire, R. P., Cremers, T. I. F. H., Dijkstra, D., van Waarde, A., & Leenders, K. L. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200405000-00007 · Cited by 22 · see citing works

Endothelial tight junctions form the blood–brain barrier

Bonetta, L. (2005) · The Journal of Cell Biology · doi:10.1083/jcb1693fta1 · Cited by 19 · see citing works

Principles of Treatment in Parkinson's Disease

(2005) · Elsevier eBooks · doi:10.1016/b978-0-7506-5428-9.x5001-x · Cited by 18 · see citing works

MPP+ Injection into Rat Substantia Nigra Causes Secondary Glial Activation but Not Cell Death in the Ipsilateral Striatum

Canudas, A. M., Fríguls, B., Planas, A. M., Gabriel, C., Escubedo, E., Camarasa, J., Camins, A., & Pallàs, M. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0308 · Cited by 18 · see citing works

Cell replacement efforts to repair neuronal injury: A potential paradigm for the treatment of Parkinson's disease

Fillmore, H. L., Holloway, K. L., & Gillies, G. T. (2005) · Neurorehabilitation · doi:10.3233/nre-2005-20309 · Cited by 17 · see citing works

Glucose transport into brain: effects of hypoglycemia.

Simpson, I. A., & Vannucci, S. J. (2002) · PubMed · Cited by 10 · see citing works

The dam breaks: disruption of the blood-brain barrier in diabetes mellitus

Banks, W. A. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00751.2006 · Cited by 8 · see citing works

Chapter 78 Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor

Carvey, P. M., McRae‐Degueurce, A., Ptak, L. R., Kao, L. C., Lo, E. S., Goetz, C., Tanner, C. M., Penn, R. D., & Klawans, H. L. (1990) · Progress in brain research · doi:10.1016/s0079-6123(08)62661-8 · Cited by 6 · see citing works

Untitled work

Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3

Structure and function of the blood–brain barrier

Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · see citing works

A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity

Kadry, H., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00230-3 · Cited by 1,853 · see citing works

Modern methods for delivery of drugs across the blood–brain barrier

Chen, Y., & Liu, L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,005 · see citing works

The Blood-Brain Barrier in Brain Homeostasis and Neurological Diseases

Weiss, N., Miller, F., Cazaubon, S., & Couraud, P.-O. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.022 · Cited by 731 · see citing works

Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases

Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708 · see citing works

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676 · see citing works

The blood-brain barrier: an engineering perspective

Wong, A. D., Ye, M., Levy, A. F., Rothstein, J. D., Bergles, D. E., & Searson, P. C. (2013) · Frontiers in Neuroengineering · doi:10.3389/fneng.2013.00007 · Cited by 662 · see citing works

Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier

Stamatovic, S. M., Keep, R. F., & Andjelkovic, A. V. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777210 · Cited by 516 · see citing works

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436 · see citing works

Targeting the transferrin receptor for brain drug delivery

Johnsen, K. B., Burkhart, A., Thomsen, L. B., Andresen, T. L., & Moos, T. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101665 · Cited by 372 · see citing works

Role of Blood-Brain Barrier in Alzheimer’s Disease

Cai, Z., Qiao, P.-F., Wan, C.-Q., Cai, M., Zhou, N.-K., & Li, Q. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180098 · Cited by 370 · see citing works

Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier

Muldoon, L. L., Alvarez, J. I., Begley, D. J., Boado, R. J., del Zoppo, G. J., Doolittle, N. D., Engelhardt, B., Hallenbeck, J. M., Lonser, R. R., Ohlfest, J. R., et al. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.153 · Cited by 327 · see citing works

IFN-γ Production by Amyloid β–Specific Th1 Cells Promotes Microglial Activation and Increases Plaque Burden in a Mouse Model of Alzheimer’s Disease

Browne, T. C., McQuillan, K., McManus, R. M., O’Reilly, J.-A., Mills, K. H. G., & Lynch, M. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200947 · Cited by 322 · see citing works

Redox Control of Microglial Function: Molecular Mechanisms and Functional Significance

Rojo, A. I., McBean, G. J., Cindrić, M., Egea, J., López, M. G., Rada, P., Žarković, N., & Cuadrado, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5745 · Cited by 313 · see citing works

Public health and components of particulate matter: The changing assessment of black carbon

Grahame, T. J., Klemm, R., & Schlesinger, R. B. (2014) · Journal of the Air & Waste Management Association · doi:10.1080/10962247.2014.912692 · Cited by 294 · see citing works

Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P‐glycoprotein up‐regulation at the blood‐brain barrier

Hartz, A. M. S., Bauer, B., Block, M. L., Hong, J., & Miller, D. S. (2008) · The FASEB Journal · doi:10.1096/fj.08-106997 · Cited by 269 · see citing works

Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy

Peng, X., Luo, Z., He, S., Zhang, L., & Li, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.768108 · Cited by 271 · see citing works

Neurovascular Unit: a Focus on Pericytes

Sá-Pereira, I., Brites, D. M. T. O., & Brito, M. A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8244-2 · Cited by 267 · see citing works

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease

Jellinger, K. A., & Attems, J. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0347-5 · Cited by 265 · see citing works

Tight Junction in Blood‐Brain Barrier: An Overview of Structure, Regulation, and Regulator Substances

Liu, W., Wang, Z., Zhang, L., Wei, X., & Li, L. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00340.x · Cited by 258 · see citing works

Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy

Theunis, C., Crespo-Biel, N., Gafner, V., Pihlgren, M., López-Deber, M. P., Reis, P., Hickman, D. T., Adolfsson, O., Chuard, N., Ndao, D. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072301 · Cited by 259 · see citing works

Inflammation and Adaptive Immunity in Parkinson's DiseasePreprint

Mosley, R. L., Hutter-Saunders, J. A. L., Stone, D. K., & Gendelman, H. E. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009381 · Cited by 246 · see citing works

Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption

Pediaditakis, I., Kodella, K. R., Manatakis, D., Le, C. Y., Hinojosa, C. D., Tien-Street, W., Manolakos, E., Vekrellis, K., Hamilton, G., Ewart, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-021-26066-5 · Cited by 174 · see citing works

Blood-brain barrier alterations in ageing and dementia

Popescu, B. O., Toescu, E. C., Popescu, L. M., Bajenaru, O. A., Muresanu, D. F., Schultzberg, M., & Bogdanović, N. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.321 · Cited by 235 · see citing works

Neuroimmunological Processes in Parkinson’s Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity

Sánchez-Guajardo, V., Barnum, C. J., Tansey, M. G., & Romero‐Ramos, M. (2013) · ASN NEURO · doi:10.1042/an20120066 · Cited by 237 · see citing works

Therapeutic Properties and Pharmacological Activities of Asiaticoside and Madecassoside: A Review

Bandopadhyay, S., Mandal, S., Ghorai, M., Jha, N. K., Kumar, M., Radha, Ghosh, A., Proćków, J., Pérez de la Lastra, J. M., & Dey, A. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17635 · Cited by 220 · see citing works

Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease

Zhang, Q.-S., Heng, Y., Mou, Z., Huang, J.-Y., Yuan, Y.-H., & Chen, N.-H. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.49 · Cited by 208 · see citing works

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

Shi, M., Kovac, A., Korff, A., Cook, T. J., Ginghina, C., Bullock, K. M., Yang, L., Stewart, T., Zheng, D., Aro, P., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.04.003 · Cited by 206 · see citing works

Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy

Blair, L. J., Frauen, H. D., Zhang, B., Nordhues, B. A., Bijan, S., Lin, Y.-C., Zamudio, F., Hernandez, L. D., Sabbagh, J. J., Selenica, M.-L. B., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0186-2 · Cited by 193 · see citing works

Caffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum

Chen, X., Lan, X., Roche, I., Liu, R., & Geiger, J. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05697.x · Cited by 189 · see citing works

Associations among Cognitive Functions, Plasma DNA, and Diffusion Tensor Image along the Perivascular Space (DTI‐ALPS) in Patients with Parkinson’s Disease

Chen, H.-L., Chen, P.-C., Lu, C.-H., Tsai, N., Yu, C.-C., Chou, K., Lai, Y., Taoka, T., & Lin, W. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4034509 · Cited by 182 · see citing works

Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood–Brain Barrier

Poller, B., Drewe, J., Krähenbühl, S., Huwyler, J., & Gutmann, H. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9431-1 · Cited by 184 · see citing works

Tau Protein and Its Role in Blood–Brain Barrier Dysfunction

Michalicová, A., Majerová, P., & Kováč, A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.570045 · Cited by 179 · see citing works

Role of Oxidative Stress in Blood–Brain Barrier Disruption and Neurodegenerative Diseases

Kim, S., Jung, U. J., & Kim, S. R. (2024) · Antioxidants · doi:10.3390/antiox13121462 · Cited by 174 · see citing works

Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics

Mukherjee, S., Madamsetty, V. S., Bhattacharya, D., Roy Chowdhury, S., Paul, M. K., & Mukherjee, A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202003054 · Cited by 152 · see citing works

Physiology of gangliosides and the role of antiganglioside antibodies in human diseases

Cutillo, G., Saariaho, A.-H., & Meri, S. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0388-9 · Cited by 154 · see citing works

Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice

Bi, M., Ittner, A., Ke, Y. D., Götz, J., & Ittner, L. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026860 · Cited by 153 · see citing works

Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy

Lau, K., Kotzur, R., & Richter, F. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00430-z · Cited by 165 · see citing works

Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis

Zhao, Z., Li, F., Ning, J., Peng, R., Shang, J., Liu, H., Shang, M., Bao, X.-Q., & Zhang, D. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.020 · Cited by 137 · see citing works

Dysfunctional Cell-Cell Signaling in the Neurovascular Unit as a Paradigm for Central Nervous System Disease

Guo, S., & Lo, E. H. (2008) · Stroke · doi:10.1161/strokeaha.108.534388 · Cited by 135 · see citing works

Microglia in Alzheimer’s disease: A multifaceted relationship

ElAli, A., & Rivest, S. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.07.021 · Cited by 134 · see citing works

GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration

Chiricozzi, E., Lunghi, G., Biase, E. D., Fazzari, M., Sonnino, S., & Mauri, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030868 · Cited by 129 · see citing works

Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques

Wikoff, W. R., Pendyala, G., Siuzdak, G. E., & Fox, H. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34138 · Cited by 131 · see citing works

Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model

Sarkar, S., Chigurupati, S., Raymick, J. B., Mann, D., Bowyer, J. F., Schmitt, T., Beger, R. D., Hanig, J. P., Schmued, L. C., & Paule, M. G. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.07.006 · Cited by 128 · see citing works

CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease

Chung, Y. C., Shin, W.-H., Baek, J. Y., Cho, E. J., Baik, H. H., Kim, S. R., Won, S.-Y., & Jin, B. K. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.100 · Cited by 126 · see citing works

Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules

Harilal, S., Jose, J., Parambi, D. G. T., Kumar, R., Unnikrishnan, M. K., Uddin, M. S., Mathew, G. E., Pratap, R., Marathakam, A., & Mathew, B. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.03.018 · Cited by 124 · see citing works

Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases

Fakhoury, M. (2015) · Neurodegenerative Diseases · doi:10.1159/000369933 · Cited by 119 · see citing works

Updates on immunity and inflammation in Parkinson disease pathology

Joshi, N., & Singh, S. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24185 · Cited by 118 · see citing works

Activated Microglia Disrupt the Blood-Brain Barrier and Induce Chemokines and Cytokines in a Rat in vitro Model

Shigemoto‐Mogami, Y., Hoshikawa, K., & Sato, K. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00494 · Cited by 118 · see citing works

Claudin‐5 regulates blood‐brain barrier permeability by modifying brain microvascular endothelial cell proliferation, migration, and adhesion to prevent lung cancer metastasis

Ma, S., Li, Q., Peng, J., Zhouwen, J., Diao, J., Niu, J., Wang, X., Guan, X., Jia, W., & Jiang, W. G. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12764 · Cited by 117 · see citing works

Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders

Xiao, M., Xiao, Z. J., Yang, B., Lan, Z., & Fang, F. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00764 · Cited by 113 · see citing works

BBB-on-a-chip with integrated micro-TEER for permeability evaluation of multi-functionalized gold nanorods against Alzheimer’s disease

Palma-Florez, S., López-Canosa, A., Moralez-Zavala, F., Castaño, Ó., Kogan, M. J., Samitier, J., Lagunas, A., & Mir, M. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01798-2 · Cited by 111 · see citing works

Non‐contrast MR imaging of blood‐brain barrier permeability to water

Lin, Z., Li, Y., Su, P., Mao, D., Wei, Z., Pillai, J. J., Moghekar, A., van Osch, M. J. P., Ge, Y., & Lu, H. (2018) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27141 · Cited by 106 · see citing works

Acteoside protects against 6-OHDA-induced dopaminergic neuron damage via Nrf2-ARE signaling pathway

Li, M., Zhou, F., Xu, T., Song, H., & Lu, B. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.06.018 · Cited by 108 · see citing works

The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's disease

ElAli, A., & Rivest, S. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00045 · Cited by 109 · see citing works

T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer’s Disease: Potential Pools of New Biomarkers

Mietelska‐Porowska, A., & Wojda, U. (2017) · Journal of Immunology Research · doi:10.1155/2017/4626540 · Cited by 107 · see citing works

Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer’s Disease: What are the Roadblocks and How Can They Be Overcome?

Banik, A., Brown, R. E., Bamburg, J., Lahiri, D. K., Khurana, D., Friedland, R. P., Chen, W., Ding, Y., Mudher, A., Padjen, A. L., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150136 · Cited by 102 · see citing works

Endothelial Dysfunction in Neurodegenerative Diseases

Fang, Y., Hsieh, Y., Hu, C., & Tu, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032909 · Cited by 101 · see citing works

Neurovascular abnormalities in humans and mice with Huntington's disease

Lin, C.-Y., Hsu, Y.-H., Lin, M.-H., Yang, T.-H., Chen, H.-M., Chen, Y.-C., Hsiao, H.-Y., Chen, C.-C., Chern, Y., & Chang, C. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.08.019 · Cited by 98 · see citing works

Differential receptor-mediated drug targeting to the diseased brain

Rip, J., Schenk, G., & de Boer, A. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902806383 · Cited by 98 · see citing works

VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer’s mice

Ali, M., Falkenhain, K., Njiru, B. N., Murtaza-Ali, M., Ruiz‐Uribe, N. E., Haft‐Javaherian, M., Catchers, S., Nishimura, N., Schaffer, C. B., & Bracko, O. (2021) · Brain · doi:10.1093/brain/awab387 · Cited by 97 · see citing works

Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre

Cai, S. C. S., Allen, J. C., Lim, Y. L., Chua, S. H., Tan, S., & Tang, M. B. Y. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12806 · Cited by 96 · see citing works

Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease

Rotunno, M. S., Lane, M., Zhang, W., Wolf, P., Oliva, P., Viel, C., Wills, A.-M., Alcalay, R. N., Scherzer, C. R., Shihabuddin, L. S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-59414-4 · Cited by 94 · see citing works

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson’s Disease

Chung, Y. C., Kim, Y.-S., Bok, E., Yune, T. Y., Maeng, S., & Jin, B. K. (2013) · Mediators of Inflammation · doi:10.1155/2013/370526 · Cited by 94 · see citing works

Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models

Carpanini, S. M., Torvell, M., Bevan, R. J., Byrne, R. A. J., Daskoulidou, N., Saito, T., Saido, T. C., Taylor, P. R., Hughes, T. R., Zelek, W. M., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01404-w · Cited by 95 · see citing works

The Role of Neurovascular System in Neurodegenerative Diseases

Ahmad, A., Patel, V., Xiao, J., & Khan, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02023-z · Cited by 94 · see citing works

Sex differences in the blood–brain barrier and neurodegenerative diseases

Weber, C. M., & Clyne, A. M. (2021) · APL Bioengineering · doi:10.1063/5.0035610 · Cited by 91 · see citing works

Angiogenic activity of nicotinic acetylcholine receptors: Implications in tobacco-related vascular diseases

Egleton, R. D., Brown, K. C., & Dasgupta, P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.007 · Cited by 91 · see citing works

Exercise and Neuroinflammation in Health and Disease

Seo, D.-Y., Heo, J.-W., Ko, J. R., & Kwak, H.-B. (2019) · International Neurourology Journal · doi:10.5213/inj.1938214.107 · Cited by 88 · see citing works

Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease

Funk, N., Wieghofer, P., Grimm, S., Schäfer, R., Bühring, H., Gasser, T., & Biskup, S. (2013) · Movement Disorders · doi:10.1002/mds.25300 · Cited by 81 · see citing works

Identifying Consensus Disease Pathways in Parkinson's Disease Using an Integrative Systems Biology Approach

Edwards, Y. J. K., Beecham, G. W., Scott, W. K., Khuri, S., Bademci, G., Tekin, D., Martin, E. R., Jiang, Z., Mash, D. C., ffrench‐Mullen, J. M. H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016917 · Cited by 80 · see citing works

Chronic cerebral hypoperfusion induces memory deficits and facilitates Aβ generation in C57BL/6J mice

Wang, L., Du, Y., Wang, K., Xu, G., Luo, S., & He, G. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.006 · Cited by 78 · see citing works

Mesenchymal stem cells stabilize the blood–brain barrier through regulation of astrocytes

Park, H. J., Shin, J. Y., Kim, H. N., Oh, S. H., Song, S. K., & Lee, P. H. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0180-4 · Cited by 79 · see citing works

Adult neurogenesis, neuroinflammation and therapeutic potential of adult neural stem cells

Taupin, P. (2008) · International Journal of Medical Sciences · doi:10.7150/ijms.5.127 · Cited by 78 · see citing works

Nerves and Neovessels Inhibit Each Other in the Cornea

Ferrari, G., Hajrasouliha, A. R., Sadrai, Z., Ueno, H., Chauhan, S. K., & Dana, R. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8379 · Cited by 75 · see citing works

Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives

La Barbera, L., Mauri, E., D’Amelio, M., & Gori, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.939855 · Cited by 74 · see citing works

Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation

ElAli, A., Thériault, P., Préfontaine, P., & Rivest, S. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-75 · Cited by 72 · see citing works

High prevalence of focal and multi-focal somatic genetic variants in the human brain

Keogh, M. J., Wei, W., Aryaman, J., Walker, L., van den Ameele, J., Coxhead, J., Wilson, I., Bashton, M., Beck, J., West, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06331-w · Cited by 74 · see citing works

The role of mutations associated with familial neurodegenerative disorders on blood–brain barrier function in an iPSC model

Katt, M. E., Mayo, L. N., Ellis, S., Mahairaki, V., Rothstein, J. D., Cheng, L., & Searson, P. C. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0139-4 · Cited by 69 · see citing works

Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia

McCaffrey, G., Seelbach, M. J., Staatz, W. D., Nametz, N., Quigley, C., Campos, C. R., Brooks, T. A., & Davis, T. P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05582.x · Cited by 71 · see citing works

Temporal and Spatial Effects of Blast Overpressure on Blood-Brain Barrier Permeability in Traumatic Brain Injury

Kuriakose, M., Rao, K. V. R., Younger, D., & Chandra, N. (2018) · Scientific Reports · doi:10.1038/s41598-018-26813-7 · Cited by 73 · see citing works

Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease

Sharma, C., Woo, H., & Kim, S. R. (2022) · Biomedicines · doi:10.3390/biomedicines10040742 · Cited by 69 · see citing works

Improvement of Impaired Motor Functions by Human Dental Exfoliated Deciduous Teeth Stem Cell-Derived Factors in a Rat Model of Parkinson’s Disease

Chen, Y.-R., Lai, P., Chien, Y., Lee, P.-H., Lai, Y., Ma, H., Shiau, C., & Wang, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113807 · Cited by 65 · see citing works

Mechanobiology of the blood-brain barrier during development, disease and ageing

Konig, S., Jayarajan, V., Wray, S., Kamm, R. D., & Moeendarbary, E. (2025) · Nature Communications · doi:10.1038/s41467-025-61888-7 · Cited by 70 · see citing works

Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice

Samantaray, S., Knaryan, V. H., Shields, D. C., Cox, A., Haque, A., & Banik, N. L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9255-6 · Cited by 64 · see citing works

The Protective Effect of Exercise in Neurodegenerative Diseases: The Potential Role of Extracellular Vesicles

Fuller, O. K., Whitham, M., Mathivanan, S., & Febbraio, M. A. (2020) · Cells · doi:10.3390/cells9102182 · Cited by 60 · see citing works

Non-invasive visualization of CNS inflammation with nuclear and optical imaging

Wunder, A. P., Klohs, J., & Dirnagl, U. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.005 · Cited by 64 · see citing works

A glycomics and proteomics study of aging and Parkinson’s disease in human brain

Raghunathan, R., Hogan, J., Labadorf, A. T., Myers, R. H., & Zaia, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-69480-3 · Cited by 63 · see citing works

Nanotechnologies: A Strategy to Overcome Blood-Brain Barrier

Rosa, G. D., Salzano, G., Caraglia, M., & Abbruzzese, A. (2011) · Current Drug Metabolism · doi:10.2174/138920012798356943 · Cited by 61 · see citing works

Current and emerging brain applications of MR-guided focused ultrasound

Meng, Y., Suppiah, S., Mithani, K., Solomon, B., Schwartz, M. L., & Lipsman, N. (2017) · Journal of Therapeutic Ultrasound · doi:10.1186/s40349-017-0105-z · Cited by 60 · see citing works

The Mechanisms of Sevoflurane-Induced Neuroinflammation

Huang, X., Ying, J., Yang, D., Fang, P., Wang, X., Zhou, B., Zhang, L., Yang, F., Yu, W., Liu, X., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.717745 · Cited by 61 · see citing works

Adult Neurogenesis, Neural Stem Cells and Alzheimers Disease: Developments, Limitations, Problems and Promises

Taupin, P. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147151 · Cited by 59 · see citing works

Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson’s disease

Cuevas, E., Burks, S., Raymick, J., Robinson, B., Gómez-Crisóstomo, N. P., Escudero-Lourdes, C., Lopez, A. G. G., Chigurupati, S., Hanig, J., Ferguson, S. A., et al. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1859729 · Cited by 57 · see citing works

Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis

Sheng, L., Stewart, T., Yang, D., Thorland, E., Soltys, D., Aro, P., Khrisat, T., Xie, Z., Li, N., Liu, Z., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00983-w · Cited by 56 · see citing works

Emerging Brain‐Pathophysiology‐Mimetic Platforms for Studying Neurodegenerative Diseases: Brain Organoids and Brains‐on‐a‐Chip

Bang, S., Lee, S., Choi, N., & Kim, H. N. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002119 · Cited by 55 · see citing works

Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases

Gao, X., Xu, J., Yao, T., Liu, X., Zhang, H., & Zhan, C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114362 · Cited by 55 · see citing works

In Vitro Modeling of the Blood-Brain Barrier: Simplicity Versus Complexity

Ogunshola, O. O. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797440159 · Cited by 52 · see citing works

Systems biology of neurodegenerative diseases

Wood, L. B., Winslow, A. R., & Strasser, S. D. (2015) · Integrative Biology · doi:10.1039/c5ib00031a · Cited by 54 · see citing works

Altered neural cell junctions and ion-channels leading to disrupted neuron communication in Parkinson’s disease

Choudhury, S. P., Bano, S., Sen, S., Suchal, K., Kumar, S., Nikolajeff, F., Dey, S. K., & Sharma, V. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00324-9 · Cited by 52 · see citing works

Human iPSC‐Derived Blood‐Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development?

Appelt‐Menzel, A., Oerter, S., Mathew, S., Haferkamp, U., Hartmann, C., Jung, M., Neuhaus, W., & Pleß, O. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.122 · Cited by 54 · see citing works

Blood Brain Barrier Dysfunction in Neurodegenerative Diseases: Molecular Mechanisms, Transport Systems, and Disease-Specific Alterations

Rehman, A., Riaz, M., Zaheer, M., Murtaza, A., Javaid, F., Shabbir, N., Naeem, M. S., Jamil, M., Noor, J., & Kharl, H. A. A. (2026) · Indus journal of bioscience research. · doi:10.70749/ijbr.v4i1.2871

The Blood Brain Barrier in Neurodegenerative Disease: A Rhetorical Perspective

Carvey, P., Hendey, B., & Monahan, A. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06319.x · Cited by 254 · see citing works

The blood–brain barrier: Gatekeeper and obstacle in neurodegenerative disorders

Bassiony, M., Ibrahem, M. A., Youssef, D. G., Elbadry, A. M. M., & Alaboudi, O. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00002-6

Blood-Brain Barrier Therapeutics for Neurological Diseases

Sahni, A., & Katchur, N. J. (2021) · Journal of Student Research · doi:10.47611/jsrhs.v10i3.1735

The blood–brain barrier as a treatment target for neurodegenerative disorders

Rust, R., Sagare, A. P., Zhang, M., Zloković, B. V., & Kisler, K. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2480654 · Cited by 20 · see citing works